Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1124994.RAbPdW0TlHPitqJl3wnKHXwskASWn-OcqKicm6orGKs50130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1124994.RAbPdW0TlHPitqJl3wnKHXwskASWn-OcqKicm6orGKs50130_assertion type Assertion NP1124994.RAbPdW0TlHPitqJl3wnKHXwskASWn-OcqKicm6orGKs50130_head.
- NP1124994.RAbPdW0TlHPitqJl3wnKHXwskASWn-OcqKicm6orGKs50130_assertion description "[Osteosarcoma and rhabdomyosarcoma showed bands corresponding to MMP-2 and -9 with dose-dependent enhancement of MMP-9 with phorbol 12-myristate 13-acetate (PMA) treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1124994.RAbPdW0TlHPitqJl3wnKHXwskASWn-OcqKicm6orGKs50130_provenance.
- NP1124994.RAbPdW0TlHPitqJl3wnKHXwskASWn-OcqKicm6orGKs50130_assertion evidence source_evidence_literature NP1124994.RAbPdW0TlHPitqJl3wnKHXwskASWn-OcqKicm6orGKs50130_provenance.
- NP1124994.RAbPdW0TlHPitqJl3wnKHXwskASWn-OcqKicm6orGKs50130_assertion SIO_000772 24190483 NP1124994.RAbPdW0TlHPitqJl3wnKHXwskASWn-OcqKicm6orGKs50130_provenance.
- NP1124994.RAbPdW0TlHPitqJl3wnKHXwskASWn-OcqKicm6orGKs50130_assertion wasDerivedFrom befree-2016 NP1124994.RAbPdW0TlHPitqJl3wnKHXwskASWn-OcqKicm6orGKs50130_provenance.
- NP1124994.RAbPdW0TlHPitqJl3wnKHXwskASWn-OcqKicm6orGKs50130_assertion wasGeneratedBy ECO_0000203 NP1124994.RAbPdW0TlHPitqJl3wnKHXwskASWn-OcqKicm6orGKs50130_provenance.